main navigation
MSGPP - Home
Project Description
  Flow Diagrams
Contact Information
  Program Project Members
Target Diseases & Organisms
* Malaria
   Plasmodium falciparum
   Plasmodium vivax
* Chagas' Disease
    [American Trypanosomiasis]
   Trypanosoma cruzi
* Sleeping Sickness
    [African Trypanosomiasis]
   Trypanosoma brucei
* Leishmaniasis
   Leishmania spp.
* Amoebiasis
   Entamoeba histolytica
* Giardiasis
   Giardia lamblia
* Toxoplasmosis
   Toxoplasma gondii
* Cryptosporidiosis
   Cryptosporidium parvum
Genome Databases
Target Progress
Ligand Screening
Papers by MSGPP
Related Links/Resources
MSGPP

MALARIA
Malaria (Plasmodium vivax)

Malaria (Plasmodium vivax) Probably ~ 10-20% of the world's cases of P. vivax infection occur in Africa, south of the Sahara. In eastern and southern Africa, P. Vivax represents around 10% of malaria cases but in less than 1% of cases in western and central Africa. Please refer to our copy of a PDF file of the entire article published in a 2001 Supplement to the "American Journal of Tropical Medicine and Hygiene" for additional information.

To view a .pdf, you will need the Adobe Reader. Get Adobe Reader

Organism Plasmodium vivax
At Risk ~70 - 80 million cases annually
Humans Infected Affects people of all ages but mostly young children
Disease Outcome  
Vaccine Prospects An effective vaccine is not available at this time
Available Drugs  
Drug Resistance Malaria parasites have become resistant & many insecticides are no longer useful

Click for larger image
[click map for larger image]

The approximate boundaries of the likely distribution of Plasmodium vivax at the maximum extent of its distribution as reached in different parts of the world between the mid-17th century and the early 20th century (light shading) and the approximate boundaries of P. vivax transmission and significant risk of infection in the late 20th century (dark shading). The boundary of malaria transmission on islands in the Western Pacific Ocean is indicated with a dashed line.
Am.J. Trop. Hyg., 64(1, 2)S.2001, pp. 97-106

General Information: Medline, World Health Organization